FI783126A - Xantinderivat - Google Patents

Xantinderivat

Info

Publication number
FI783126A
FI783126A FI783126A FI783126A FI783126A FI 783126 A FI783126 A FI 783126A FI 783126 A FI783126 A FI 783126A FI 783126 A FI783126 A FI 783126A FI 783126 A FI783126 A FI 783126A
Authority
FI
Finland
Prior art keywords
xantinderivat
Prior art date
Application number
FI783126A
Other languages
English (en)
Other versions
FI66383C (fi
FI66383B (fi
Inventor
Sten Haokan Axel Ma Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of FI783126A publication Critical patent/FI783126A/fi
Application granted granted Critical
Publication of FI66383B publication Critical patent/FI66383B/fi
Publication of FI66383C publication Critical patent/FI66383C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI783126A 1977-10-14 1978-10-13 Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat FI66383C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7711581 1977-10-14

Publications (3)

Publication Number Publication Date
FI783126A true FI783126A (fi) 1979-04-15
FI66383B FI66383B (fi) 1984-06-29
FI66383C FI66383C (fi) 1984-10-10

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783126A FI66383C (fi) 1977-10-14 1978-10-13 Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat

Country Status (21)

Country Link
US (1) US4233303A (fi)
EP (1) EP0001735B1 (fi)
JP (1) JPS5479296A (fi)
AT (1) AT363491B (fi)
AU (1) AU521585B2 (fi)
CA (1) CA1109470A (fi)
CS (1) CS208756B2 (fi)
DD (1) DD139855A5 (fi)
DE (1) DE2862017D1 (fi)
DK (1) DK148260C (fi)
FI (1) FI66383C (fi)
HK (1) HK6385A (fi)
HU (1) HU180219B (fi)
IE (1) IE47884B1 (fi)
IT (1) IT1109208B (fi)
NO (1) NO147562C (fi)
NZ (1) NZ188566A (fi)
SE (1) SE416810C (fi)
SG (1) SG85584G (fi)
SU (1) SU755199A3 (fi)
ZA (1) ZA785335B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
CA2206804C (en) * 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
WO2004096228A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
MXPA06011823A (es) * 2004-04-16 2006-12-15 Novacardia Inc Terapia de combinacion, que comprende un antagonista del receptor de la adenosina a1 y un inhibidor de la aldosterona.
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
IT7851499A0 (it) 1978-10-13
EP0001735B1 (en) 1982-09-01
AT363491B (de) 1981-08-10
NO147562B (no) 1983-01-24
DE2862017D1 (en) 1982-10-28
IE782041L (en) 1979-04-14
SU755199A3 (en) 1980-08-07
IE47884B1 (en) 1984-07-11
AU521585B2 (en) 1982-04-22
CA1109470A (en) 1981-09-22
US4233303A (en) 1980-11-11
ATA714478A (de) 1980-09-15
FI66383C (fi) 1984-10-10
DK148260B (da) 1985-05-20
ZA785335B (en) 1979-09-26
HU180219B (en) 1983-02-28
NO783471L (no) 1979-04-18
AU4036578A (en) 1980-04-17
HK6385A (en) 1985-02-01
SG85584G (en) 1985-06-07
SE416810B (sv) 1981-02-09
CS208756B2 (en) 1981-09-15
SE7711581L (sv) 1979-04-15
SE416810C (sv) 1982-07-19
NO147562C (no) 1983-05-18
DK148260C (da) 1986-02-10
JPS5479296A (en) 1979-06-25
IT1109208B (it) 1985-12-16
NZ188566A (en) 1984-07-06
DK453778A (da) 1979-04-15
FI66383B (fi) 1984-06-29
EP0001735A1 (en) 1979-05-02
DD139855A5 (de) 1980-01-23

Similar Documents

Publication Publication Date Title
DK538778A (da) Samlebaandsanlaeg
DD132145A5 (de) Fluessigkeitsregelventil
DK145040C (da) Aeggebakke
FI770610A (fi) Tissuepappersmaskin
DD138373A5 (de) Bildbetrachtungsgeraet
DK560678A (da) Saenksmedeapparat
BE865477A (fr) Waarschuwingssysteem
DK221778A (da) Drivrem
DD135363A5 (de) Nietnagel
BE867184A (fr) Lingotieres
FI55019B (fi) Silourlastningsanordning
FI771788A (fi) Vattenledningsarmatur
FI65879B (fi) Rasterdistorsions-korrigeringskrets
BR7804786A (pt) Rateira
DD138694A5 (de) Tuerbetaetigungsvorrichtung
BE866766A (fr) Ventilateur-depoussiereur
DK491378A (da) Kaernekasse
DK519278A (da) Ventilsaek
DD131224A1 (de) Staubsaugermundstueck
FI771025A (fi) Kylrum
DK312078A (da) Tremmerist
FI55416B (fi) Kontrollsystem foer centralvaermning
FI54642B (fi) Bergskyddsrum
DD133167A1 (de) Hubkolbenkraftmaschine
FI773394A (fi) Baotdaevert

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AKTIEBOLAGET DRACO